First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children.

Autor: Tiono, Alfred B.1, Nébié, Issa1, Anagnostou, Nicholas2, Coulibaly, Aboubacar S.1, Bowyer, Georgina2, Lam, Erika2, Bougouma, Edith C.1, Ouedraogo, Alphonse1, Yaro, Jean Baptist B.1, Barry, Aïssata1, Roberts, Rachel2, Rampling, Tommy2, Bliss, Carly2, Hodgson, Susanne2, Lawrie, Alison2, Ouedraogo, Amidou1, Imoukhuede, Egeruan Babatunde2, Ewer, Katie J.2, Viebig, Nicola K.3, Diarra, Amidou1
Zdroj: PLoS ONE. 12/12/2018, Vol. 13 Issue 12, p1-19. 19p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje